Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pharmacogenomics and pharmainformatics].

Toshio Tanaka1, Yuhei Nishimura, Hiroshi Tsunoda

  • 1Department of Molecular and Cellular Pharmacology, Mie University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 26, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-PM/Scl antibody-positive myositis with muscle pathology resembling anti-synthetase syndrome.

Modern rheumatology case reports·2026
Same author

Folic Acid Alleviates X-Ray Irradiation-Induced Jaw Malformation in Zebrafish.

Congenital anomalies·2026
Same author

Advancing Developmental and Reproductive Toxicity Research: Mechanistic Coverage, NAM Approaches, and Integrative Strategies.

Current research in toxicology·2026
Same author

Marine or freshwater food? The dilemma of Eurasian otter (Lutra lutra) along Bulgarian Black Sea coast.

BMC zoology·2026
Same author

Deer fear bear? A test of nonconsumptive effects on sika deer by an omnivorous Asiatic black bear.

Current zoology·2026
Same author

[Preface].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica·2026

Pharmacogenomics uses gene expression analysis to find new drug targets. Heme oxygenase-1 (HO-1) gene induction shows therapeutic potential for treating cerebral vasospasm and related conditions.

Area of Science:

  • Pharmacogenomics
  • Molecular Biology
  • Genomics

Context:

  • Pharmacogenomics aims to identify genes influencing drug response.
  • Genome sequencing, transcriptome, and proteome analysis are key tools.
  • Understanding gene expression changes aids in disease and treatment response prediction.

Purpose:

  • To identify therapeutic target genes using transcriptome analysis in animal models of cerebral vasospasm and hypoxia/ischemia.
  • To explore the role of heme oxygenase-1 (HO-1) in cerebral vasospasm.
  • To evaluate HO-1 gene induction as a therapeutic strategy.

Summary:

  • Transcriptome analysis identified up-regulation of heme oxygenase-1 (HO-1) mRNA in cerebral vasospasm models.
  • Intrathecal administration of antisense HO-1 oligodeoxynucleotide aggravated vasospasm, indicating HO-1 gene induction has spasmolytic effects.

Related Experiment Videos

  • HO-1 gene induction demonstrated protective effects in cerebral vasospasm, suggesting its therapeutic potential.

    • Impact:

    • Therapeutic gene induction of HO-1 offers a novel strategy for preventing and treating hemoglobin-induced pathologies, including delayed cerebral vasospasm.
    • Pharmacogenomic transcriptome analysis and pharmainformatics can identify novel drug targets for various diseases.
    • This research highlights the potential of HO-1 as a therapeutic target for cerebrovascular disorders.